- Home
- WNS vs LGND Comparison
WNS vs LGND Comparison
Compare WNS & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNS
- LGND
- Stock Information
- Founded
- WNS 1996
- LGND 1987
- Country
- WNS India
- LGND United States
- Employees
- WNS N/A
- LGND N/A
- Industry
- WNS Business Services
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- WNS Consumer Discretionary
- LGND Health Care
- Exchange
- WNS Nasdaq
- LGND Nasdaq
- Market Cap
- WNS 2.1B
- LGND 2.0B
- IPO Year
- WNS N/A
- LGND 1992
- Fundamental
- Price
- WNS $50.50
- LGND $111.71
- Analyst Decision
- WNS Buy
- LGND Strong Buy
- Analyst Count
- WNS 7
- LGND 6
- Target Price
- WNS $60.43
- LGND $144.83
- AVG Volume (30 Days)
- WNS 578.2K
- LGND 142.9K
- Earning Date
- WNS 10-17-2024
- LGND 11-07-2024
- Dividend Yield
- WNS N/A
- LGND N/A
- EPS Growth
- WNS N/A
- LGND 160.46
- EPS
- WNS 2.50
- LGND 2.47
- Revenue
- WNS $1,308,696,000.00
- LGND $152,422,000.00
- Revenue This Year
- WNS N/A
- LGND $23.19
- Revenue Next Year
- WNS $7.96
- LGND $15.08
- P/E Ratio
- WNS $20.22
- LGND $45.20
- Revenue Growth
- WNS 2.07
- LGND N/A
- 52 Week Low
- WNS $39.85
- LGND $57.00
- 52 Week High
- WNS $72.57
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- WNS 48.97
- LGND 48.80
- Support Level
- WNS $50.16
- LGND $119.69
- Resistance Level
- WNS $55.86
- LGND $125.76
- Average True Range (ATR)
- WNS 1.80
- LGND 5.73
- MACD
- WNS 0.41
- LGND -0.30
- Stochastic Oscillator
- WNS 42.74
- LGND 25.51
About WNS WNS (Holdings) Limited Sponsored ADR (Jersey)
WNS (Holdings) Ltd is a Global provider of business process management (BPM) services, offering comprehensive data, voice, analytical, and business transformation services with a blended onshore, nearshore and offshore delivery model. The company's segment includes Banking/Financial Services, and Insurance; Travel, Shipping/Logistics, and Utilities; Manufacturing/Retail/Consumer, Hi-tech/Professional Services, and Procurement; Healthcare/Life Sciences. Geographically the company generates the majority of its revenue from North America (primarily the US), followed by the UK. The company also has a presence in Australia, Europe (excluding the UK), and South Africa.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.